awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745424-283C725F-6CDF-4A3A-9EFA-6566E6B4A180
Q26745424-283C725F-6CDF-4A3A-9EFA-6566E6B4A180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-283C725F-6CDF-4A3A-9EFA-6566E6B4A180
Nintedanib in NSCLC: evidence to date and place in therapy
P2860
Q26745424-283C725F-6CDF-4A3A-9EFA-6566E6B4A180
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-283C725F-6CDF-4A3A-9EFA-6566E6B4A180
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1864400b85f223161c06a4014736d83f3295965
P2860
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer.